["{\n\"step_by_step_thinking\": \"The question is about a 46-year-old woman with active ankylosing spondylitis who has tried various conventional nonsteroidal anti-inflammatory drugs and sulfasalazine without improvement. The patient requires a new treatment approach. Given that the patient has an autoimmune disease, it's likely that the next step in treatment would involve addressing the underlying inflammatory process. Among the options, tumor necrosis factor α (TNF-α) is a key cytokine involved in inflammation and is targeted by many biologics used to treat conditions like ankylosing spondylitis.\",\n\"answer_choice\": D"]